•HDAC6
is localized exclusively in the cytoplasm in contrast to most HDACs which are
transiently or permanently localized in the nucleus and does not catalyze
histone deacetylationin
vivo.
•Several
HDAC6 selective inhibitors that can be developed as promising therapies for
autoimmune, oncology and inflammation indications